To determine the minimum scan duration for fluorine-18 positron-emitting radioactive isotope-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) scans performed on a total-body PET/CT scanner that results in non-inferior image quality to 18F-FDG PET/CT scans performed on a conventional PET/CT scanner. The subject population will be patients being staged for lung cancer, lymphoma, or melanoma.
Ability to understand and willingness to sign an informed consent form. Ability to adhere to the study visit schedule and all protocol requirements. Men and women ≥18 years of age. Diagnosis or suspected diagnosis of lung cancer, melanoma or lymphoma. Patients who have been referred for a PET/CT scan.
Exclusion Criteria:
Pregnant women. Claustrophobia. Any significant medical condition that in the opinion of the investigator would prevent the subject from participating and/or adhering to study related procedures or interfere with subject safety.
